Stock Analiz

Edap Tms SA FOCL

Biotechnology: Electromedical & Electrotherapeutic Apparatus · data as of November 13, 2026

$3.25Market cap $153M
Open the interactive analysis →

Edap Tms SA (FOCL) is a healthcare company listed in the US with a market value of about $153M. In fiscal year 2025 it had revenue of $71M and net income of -$29M, a net margin of -41.5%.

Its overall Stock Analiz score is 0.4 out of 5 (weak). The strongest part is future growth (2/5); the weakest is value (0/5).

Key numbers: 5-year revenue growth of 7% a year, a 5-year average ROIC of -42%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 67% below the current price.

About Edap Tms SA

Edap Tms SA is listed in the US and classified in biotechnology: electromedical & electrotherapeutic apparatus. Revenue went from $20M in 2013 to $71M in 2025, growth of about 10.9% a year. It was profitable in 1 of the last 10 years in our data. It spends 14% of revenue on research and development.

Score: 0.4 / 5

Value0/5
Future growth2/5
Track record0/5
Financial health0/5
Shareholder returns0/5

Checks passed

  • 3-year revenue growth above 10% a year
  • Strong R&D investment or growth above 20%

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • Profit margin improving
  • 3-year free cash flow growth above 10% a year

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S2.2
P/B7.9
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield—
Shareholder yield0.0%
Intrinsic value vs. price−67%

Growth and quality

Revenue growth (1 yr)1.6%
Revenue growth (5 yrs, per year)7.0%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-35.6%
ROIC (5-yr avg.)-41.6%
Profitable years (of last 10)1
Years paying a dividend—

Financials, last 10 years

Fiscal year2025202420222021202020192018201720162015
Revenue$71M$69M$59M$50M$51M$50M$45M$43M—$24M
Net income-$29M-$21M————-$387M-$817M$4.1B-$1.8B
Free cash flow——————————
EPS (diluted)$-0.62$-0.44————$-8.21$-17.30$85.77$-38.43
Net margin-41.5%-29.7%————-864.0%-1909.3%—-7608.2%
ROIC-48.1%-35.2%————————

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Is Edap Tms SA stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 67% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Edap Tms SA pay a dividend?

Not currently.

Is Edap Tms SA a good stock to buy?

We do not give buy or sell advice. Edap Tms SA scores 0.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.